Page 1 of 3 pages :  1 2 3 >

1. Clinical Case Review: Thyroid Function Abnormalities in Patients Receiving VEGF-Targeted Therapy

H&O April 2011 Volume 9, Issue 4

Brian I. Rini, MD

Download PDF

2. Clinical Case Study: Clinical Hypothyroidism in a Renal Cell Carcinoma Patient Treated With Sorafenib

H&O April 2011 Volume 9, Issue 4

Matthew S. Block, MD, PhD, and Manish Kohli, MD

Download PDF

3. Feature Article: Resistance to Angiogenesis Inhibitors in Renal Cell Carcinoma

H&O February 2011 Volume 9, Issue 2

Ila Tamaskar, MD, Jaspreet Dhillon, MD, and Roberto Pili, MD

Download PDF

4. Clinical Case Review: Therapy for Kidney Cancer With a Sarcomatoid Component

H&O January 2011 Volume 9, Issue 1

Mayer Fishman, MD, PhD

Download PDF

5. Clinical Case Study: A 51-Year-Old Man With Rapidly Progressive Metastatic Sarcomatoid Renal Cell Carcinoma: An Apparent Complete Clinical Response to Second-Line Therapy With Sunitinib and Low-Dose Interferon-Alpha

H&O January 2011 Volume 9, Issue 1

Michael J. Bradshaw, John C. Cheville, MD, and Gary A. Croghan, PhD, MD

Download PDF

6. Renal Cell Carcinoma In Focus: Improving the Therapeutic Index of IL-2

H&O December 2010 Volume 8, Issue 12

David F. McDermott, MD

Download PDF

7. Renal Cell Carcinoma In Focus: Combination Therapy in Patients With Metastatic Renal Cell Carcinoma

H&O October 2010 Volume 8, Issue 10

Bernard J. Escudier, MD

Download PDF

8. Renal Cell Carcinoma In Focus: Biomarkers: Hypertension Following Anti-angiogenesis Therapy

H&O June 2010 Volume 8, Issue 6

Brian I. Rini, MD

Download PDF

9. Feature Article: Molecularly Targeted Agents for Renal Cell Carcinoma: The Next Generation

H&O May 2010 Volume 8, Issue 5

C. Lance Cowey, MD, and Thomas E. Hutson, DO, PharmD, FACP

Download PDF

10. Renal Cell Carcinoma In Focus: Pazopanib in Renal Cell Carcinoma

H&O April 2010 Volume 8, Issue 4

Cora N. Sternberg, MD, FACP

Download PDF

Page 1 of 3 pages :  1 2 3 >